Simplyhealth launches £60m venture capital fund

The fund forms part of Simplyhealth's venture capital schemes with a focus on investment in early-stage healthcare businesses to support its growth and development, specifically on innovation in predictive and preventative healthcare  The mutual has invested an undisclosed amount into Daye, a gynaecological health company which creates products such as relief for period pain, at-home STI testing and the treatment of vaginal infections. The funding will enable Daye to expand its offering from menstruation to vaginal microbiome screening. Dr Sneh Khemka, chief executive at Simplyheal...